Efficacy and Safety Study of Sorafenib With Topotecan in Patients With Platinum-resistant Recurrent Ovarian Cancer

NCT01047891 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
174
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

JSehouli